New blood test may predict infection risk after liver transplant

NCT ID NCT07647978

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to create a score that predicts the risk of infection within 30 days after a liver transplant. Researchers will collect blood samples from 279 liver transplant patients before and after surgery to measure immune markers. The goal is to combine these markers with other clinical factors to better identify high-risk patients and potentially improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a tool that helps doctors identify patients at high risk of infection after liver transplant, allowing earlier intervention.
What could go wrong
This is an observational study that does not test a new treatment. The predictive score may not be accurate enough for routine use, and results may not apply to all transplant centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE FULMINANT HEPATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Hepatology and Gastroenterology - CHU de Clermont Ferrand

    Clermont-Ferrand, 63100, France

  • Department of Hepatology and Gastroenterology - Hôpital Saint Eloi

    Montpellier, 34090, France

  • Department of Hepatology and Gastroenterology - Hôpital de la Croix-Rousse

    Lyon, 69004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.